T cell receptor-induced phosphoinositide-3-kinase p110δ activity is required for T cell localization to antigenic tissue in mice

被引:48
作者
Jarmin, Sarah J. [1 ]
David, Rachel [1 ]
Ma, Liang [1 ]
Chai, Jan-Guo [1 ]
Dewchand, Hamlata [1 ]
Takesono, Aya [2 ]
Ridley, Anne J. [2 ]
Okkenhaug, Klaus [3 ]
Marelli-Berg, Federica M. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Div Med, London W12 0NN, England
[2] UCL, Ludwig Inst Canc Res, London, England
[3] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
D O I
10.1172/JCI33267
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The establishment of T cell-mediated inflammation requires the migration of primed T lymphocytes from the blood stream and their retention in antigenic sites. While naive T lymphocyte recirculation in the lymph and blood is constitutively regulated and occurs in the absence of inflammation, the recruitment of primed T cells to nonlymphoid tissue and their retention at the site are enhanced by various inflammatory signals, including TCR engagement by antigen-displaying endothelium and resident antigen-presenting cells. in this study, we investigated whether signals downstream of TCR ligation mediated by the phosphoinositide-3-kinase (PI3K) subunit p110 delta contributed to the regulation of these events. T lymphocytes from mice expressing catalytically inactive p110 delta displayed normal constitutive trafficking and migratory responses to nonspecific stimuli. However, these cells lost susceptibility to TCR-induced migration and failed to localize efficiently to antigenic tissue. Importantly, we showed that antigen-induced T cell trafficking and subsequent inflammation was abrogated by selective pharmacological inhibition of PI3K p110 delta activity. These observations suggest that pharmacological targeting of p110 delta activity is a viable strategy for the therapy of T cell-mediated pathology.
引用
收藏
页码:1154 / 1164
页数:11
相关论文
共 38 条
[11]   The p110δ subunit of phosphoinositide 3-kinase is required for the lipopolysaccharide response of mouse B cells [J].
Hebeis, BJ ;
Vigorito, E ;
Turner, M .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 :789-791
[12]   Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism [J].
James, MJ ;
Belaramani, L ;
Prodromidou, K ;
Datta, A ;
Nourshargh, S ;
Lombardi, G ;
Dyson, J ;
Scott, D ;
Simpson, E ;
Cardozo, L ;
Warrens, A ;
Szydlo, RM ;
Lechler, RI ;
Marelli-Berg, FM .
BLOOD, 2003, 102 (06) :2173-2179
[13]  
Kawai T, 1998, IMMUNOLOGY, V93, P11
[14]   CXCR4 physically associates with the T cell receptor to signal in T cells [J].
Kumar, Ashok ;
Hurnphreys, Troy D. ;
Kremer, Kimberly N. ;
Bramati, Patricia S. ;
Bradfield, Lavone ;
Edgar, Contessa E. ;
Hedin, Karen E. .
IMMUNITY, 2006, 25 (02) :213-224
[15]   Isolation of endothelial cells from murine tissue [J].
Marelli-Berg, FM ;
Peek, E ;
Lidington, EA ;
Stauss, HJ ;
Lechler, RI .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 244 (1-2) :205-215
[16]  
Marelli-Berg FM, 1999, J IMMUNOL, V162, P696
[17]   Cognate recognition of the endothelium induces HY-specific CD8+ T-lymphocyte transendothelial migration (diapedesis) in vivo [J].
Marelli-Berg, FM ;
James, MJ ;
Dangerfield, J ;
Dyson, J ;
Millrain, M ;
Scott, D ;
Simpson, E ;
Nourshargh, S ;
Lechler, RI .
BLOOD, 2004, 103 (08) :3111-3116
[18]   Lack of T cell proliferation without induction of nonresponsiveness after antigen presentation by endothelial cells [J].
Marelli-Berg, FM ;
Frasca, L ;
Imani, N ;
Lombardi, G ;
Lechler, RI .
TRANSPLANTATION, 1999, 68 (02) :280-287
[19]   Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node [J].
Matheu, Melanie P. ;
Deane, Jonathan A. ;
Parker, Ian ;
Fruman, David A. ;
Cahalan, Michael D. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (04) :2261-2269
[20]   Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis [J].
Millrain, M ;
Chandler, P ;
Dazzi, F ;
Scott, D ;
Simpson, E ;
Dyson, PJ .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3756-3764